Although the exact mechanism by which the loss of function of ALK1 and endoglin activates VEGF signaling has not been established, it has become clear that VEGF/VEGFR2 signaling is a critical part of the pathogenic process of HHT and a promising therapeutic target. Here, VEGFA is linked to hereditary hemorrhagic telangiectasia.